Pre- and Neonatal Imprinting on Immunological Homeostasis and Epithelial Barrier Integrity by Escherichia coli Nissle 1917 Prevents Allergic Poly-Sensitization in Mice

Pre- and Neonatal Imprinting on Immunological Homeostasis and Epithelial Barrier Integrity by Escherichia coli Nissle 1917 Prevents Allergic Poly-Sensitization in Mice

A steady rise in the number of poly-sensitized patients has increased the demand for effective prophylactic strategies against multi-sensitivities. Probiotic bacteria have been successfully used in clinics and experimental models to prevent allergic mono-sensitization. In the present study, we have...

Full description

Bibliographic Details
Main Authors:	Priya J. Sarate, Dagmar Srutkova, Nora Geissler, Martin Schwarzer, Irma Schabussova, Aleksandra Inic-Kanada, Hana Kozakova, Ursula Wiedermann
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Immunology
Subjects:	allergic poly-sensitization germ-free BALB/c mucosal tolerance mouse model Escherichia coli Nissle 1917
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.612775/full

Similar Items

Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01)

Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda ALTUNTAŞ, et al.
Published: (2017-12-01)

Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01)

Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01)

Inhibitory Effect of E. coli Nissle 1917 on Clinical and Standard Strains of Pseudomonas aeruginosa
by: Sheyda Damoogh, et al.
Published: (2021-01-01)

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic <i>Escherichia coli</i> Nissle 1917
by: Otakar Dusek, et al.
Published: (2020-12-01)

Transcriptional Profiling of the Probiotic <i>Escherichia coli</i> Nissle 1917 Strain under Simulated Microgravity
by: Jaewoo Yim, et al.
Published: (2020-04-01)

Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment
by: Rui Zhao, et al.
Published: (2022-12-01)

Escherichia coli Nissle 1917 inhibits biofilm formation and mitigates virulence in Pseudomonas aeruginosa
by: Ahmad M. Aljohani, et al.
Published: (2023-03-01)

Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies
by: Haojie Chen, et al.
Published: (2023-02-01)

Wild-type Escherichia coli Nissle 1917 improves hyperuricemia by anaerobically degrading uric acid and maintaining gut microbiota profile of mice
by: Yanmei Sun, et al.
Published: (2024-01-01)

A comparative study on the genomes, transcriptomes, and metabolic properties of Escherichia coli strains Nissle 1917, BL21(DE3), and MG1655
by: Linlin Zhao, et al.
Published: (2022-03-01)

Minimizing endogenous cryptic plasmids to construct antibiotic-free expression systems for Escherichia coli Nissle 1917
by: Siyan Zhou, et al.
Published: (2024-03-01)

In Vitro Evaluation of the Impact of the Probiotic E. coli Nissle 1917 on Campylobacter jejuni’s Invasion and Intracellular Survival in Human Colonic Cells
by: Yosra A. Helmy, et al.
Published: (2017-08-01)

Effects of Escherichia coli Nissle 1917 on the Porcine Gut Microbiota, Intestinal Epithelium and Immune System in Early Life
by: Mirelle Geervliet, et al.
Published: (2022-02-01)

Antibacterial MccM as the Major Microcin in <i>Escherichia coli</i> Nissle 1917 against Pathogenic Enterobacteria
by: Yi Ma, et al.
Published: (2023-07-01)

Anti-cancer properties of Escherichia coli Nissle 1917 against HT-29 colon cancer cells through regulation of Bax/Bcl-xL and AKT/PTEN signaling pathways
by: Siamak Alizadeh, et al.
Published: (2020-07-01)

The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
by: Susanne Bury, et al.
Published: (2018-05-01)

K5 Capsule and Lipopolysaccharide Are Important in Resistance to T4 Phage Attack in Probiotic E. coli Strain Nissle 1917
by: Manonmani Soundararajan, et al.
Published: (2019-11-01)

Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP‐1 and modulating gut microbiota
by: Heng Wu, et al.
Published: (2023-09-01)

Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles modulate the intestinal microbiome and host gut-liver metabolome in obese and diabetic mice
by: Jun Shi, et al.
Published: (2023-08-01)

High-quality genome-scale metabolic network reconstruction of probiotic bacterium Escherichia coli Nissle 1917
by: Max van ‘t Hof, et al.
Published: (2022-12-01)

Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy
by: Lian He, et al.
Published: (2019-06-01)

Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages
by: Rujiu Hu, et al.
Published: (2020-08-01)

Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic <i>Escherichia coli</i> Strain Nissle 1917
by: Dohyeon Kim, et al.
Published: (2021-02-01)

Probiotic Escherichia coli Nissle 1917 protect chicks from damage caused by Salmonella enterica serovar Enteritidis colonization
by: Shu Wu, et al.
Published: (2023-09-01)

E. coli Nissle 1917 ameliorates mitochondrial injury of granulosa cells in polycystic ovary syndrome through promoting gut immune factor IL-22 via gut microbiota and microbial metabolism
by: Man Luo, et al.
Published: (2023-05-01)

The Combined Escherichia coli Nissle 1917 and Tryptophan Treatment Modulates Immune and Metabolome Responses to Human Rotavirus Infection in a Human Infant Fecal Microbiota-Transplanted Malnourished Gnotobiotic Pig Model
by: Husheem Michael, et al.
Published: (2022-10-01)

Deciphering the Crucial Roles of the Quorum-Sensing Transcription Factor SdiA in NADPH Metabolism and (<i>S</i>)-Equol Production in <i>Escherichia coli</i> Nissle 1917
by: Zhe Wang, et al.
Published: (2024-02-01)

<i>Escherichia</i><i>coli</i> Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy
by: Qingyao Liu, et al.
Published: (2021-08-01)

Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction
by: Thomas Secher, et al.
Published: (2017-09-01)

<i>Escherichia coli</i> Nissle 1917 Antagonizes <i>Candida albicans</i> Growth and Protects Intestinal Cells from <i>C. albicans</i>-Mediated Damage
by: Yasmine Rebai, et al.
Published: (2023-07-01)

Supplementation of Labneh with Passion Fruit Peel Enhanced Survival of <i>E. coli</i> Nissle 1917 during Simulated Gastrointestinal Digestion and Adhesion to Caco-2 Cells
by: Mohamed Samir Darwish, et al.
Published: (2022-06-01)

Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction
by: Carina-Shianya Alvarez, et al.
Published: (2019-07-01)

2-Ketogluconic acid and pyrroloquinoline quinone secreting probiotic Escherichia coli Nissle 1917 as a dietary strategy against heavy metal induced damage in rats
by: Ruma Raghuvanshi, et al.
Published: (2017-10-01)

Tumor Colonization and Therapy by <i>Escherichia coli</i> Nissle 1917 Strain in Syngeneic Tumor-Bearing Mice Is Strongly Affected by the Gut Microbiome
by: Ivaylo Gentschev, et al.
Published: (2022-12-01)

Comprehensive probiogenomics analysis of the commensal Escherichia coli CEC15 as a potential probiotic strain
by: Tales Fernando da Silva, et al.
Published: (2023-11-01)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
by: Soo-Kyung Park, et al.
Published: (2022-09-01)

Franz Nissl (1860-1919), noted neuropsychiatrist and neuropathologist, staining the neuron, but not limiting it
by: Marleide da Mota Gomes
Published: (2019-09-01)

Germ-Free Mice Exhibit Mast Cells With Impaired Functionality and Gut Homing and Do Not Develop Food Allergy
by: Martin Schwarzer, et al.
Published: (2019-02-01)